| Parotelli, Roberto (Bayer Healthcare 200804 Head Diabetes Care Europe) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Parr, Maria (FU Berlin 201909 Professor) |
Professor |
Freie Universität Berlin (FU Berlin, Free University Berlin) |
Germany |
| Parrett, William G. (Deloite Touche –2007 retired) |
n. a. |
Deloitte Touche Tohmatsu (Group) |
United Kingdom (GB) |
| Parrisius, Jürgen (ActeaVentures 201403– Managing Partner before JP BioConsulting + Pfizer + Roche + Cardion) |
Managing Director |
ActeaVentures GmbH |
Germany |
| Parry, Rob (AvanSci Bio 201412 CEO) |
Chief Executive Officer (CEO) |
AvanSci Bio LLC |
United States (USA) |
| Parthoens, Alain (Newton Biocapital 201810 Managing Director before Vesalius Biocapital) |
Managing Partner (investment firm) |
Newton Biocapital S.A. |
Belgium |
| Paschinger, Ira (PR&D (AT) 201805) |
Public Relations Manager / Investor Relations Manager |
PR&D – Public Relations für Forschung & Bildung GmbH |
Austria |
| Paschlau, Joachim (ERC GmbH 201105 Managing Director) |
Managing Director |
ERC Gesellschaft für den Vertrieb wissenschaftlicher Geräte mbH (ERC GmbH) |
Germany |
| Pasini, Alexandre (Celonic 202110– COO before SaniSure Group + Lonza Group) |
Chief Operating Officer (COO) |
Celonic (Group) |
Switzerland |
| Pasquier, Olivier (Prestodiag 201405 VP Sales + Marketing before Abaxxi + Cytoo + Qiagen) |
Sales Manager / Marketing Manager |
Prestodiag S.A.S. |
France |
| Passmore, David (Yumab 202005 Business Development) |
Business Development Manager / Strategy Manager |
Yumab (Group) |
United States (USA) |
| Pasternack, Ralf (Zedira 201106 Managing Director + co-founder before N-Zyme Biotec 200506 Managing Director) |
Managing Director |
Zedira GmbH |
Germany |
| Patel, Sanjay S. (Immunic 201907– CFO before Pernix Therapeutics + Cantor Fitzgerald + Clinton Foundation + Cowen) |
Chief Financial Officer (CFO) |
Immunic (Group) |
United States (USA) |
| Patel, Umesh A. (Merck (DE) 201112 Direct Lead Discovery at EMD Millipore) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Pattberg, Holger (CMS 201806 Counsel at CMS) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Pauer, Michael (Occident Group 201604 Investment Director) |
Investment Manager |
Occident Group AG |
Switzerland |
| Paul, Les (Molecular Health 201607– CMO based in Boston before Caris Life Sciences + Intermune + Novartis) |
Chief Medical Officer (CMO) |
Molecular Health (Group) |
Germany |
| Paul, Wolfgang (Univ Bonn Professor *1913–+1993) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Pauli, Peter (BayBG 201110 Managing Director) |
Managing Director |
Bavaria (govt region) |
Germany |
| Paulick, Katharina (BioNukleo GmbH 201808 Managing Partner) |
Managing Director |
BioNukleo GmbH |
Germany |
| Paulista, Michael (Biopharm GmbH 201311 Managing Director) |
Managing Director |
Biopharm (Group) |
Germany |
| Paulitschke, Manrico (Provitro GmbH 201210 Managing Director) |
Managing Director |
Provitro AG |
Germany |
| Paulsen, Frederik (Ferring 201911 Chairman) |
Board member |
Ferring (Paulsen Foundation) (Group) |
Switzerland |
| Paulsen, Richard (Ipsen 201801– EVP + CEO North America before 10 years at Amgen) |
Regional manager |
Ipsen (Group) |
France |
| Paust, Thomas (Sartorius 201204 VP Supply Chain Management at Sartorius Stedim Biotech) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Pauwels, Rudi (Biocartis 201111 Executive Chairman before 201002–201111 CEO) |
Chief Executive Officer (CEO) |
Biocartis (Group) |
Switzerland |
| Pavkovic, Damir (Norgenta 201211 Manager Marketing) |
Sales Manager / Marketing Manager |
Hamburg (govt region) |
Germany |
| Pawela, Natalia (Selvita 201109 Media Contact) |
Public Relations Manager / Investor Relations Manager |
Selvita (Group) |
Poland |
| Pawlak, Michael (Zeptosens Co-Founder) |
Company Founder |
Bayer (Group) |
Switzerland |
| Pawliszyn, Janusz (Univ Waterloo 201912 Prof + JP Scientific 201912 Founder + Board Member) |
Professor |
University of Waterloo |
Canada |
| Payne, Lloyd (ArrePath 202110– CEO before Evotec + Euprotec) |
Chief Executive Officer (CEO) |
ArrePath (US) |
United States (USA) |
| Payne, Rob (Evonik 201308 Director of Nutrition + Technical Sales forAsia South) |
Sales Manager / Marketing Manager |
Evonik (Group) |
Germany |
| Payner, Brendan (Precision Medicine Group 202201 at Stern IR) |
Public Relations Manager / Investor Relations Manager |
Precision Medicine Group (Group) |
United States (USA) |
| Pè, Giulio (Mettler-Toledo 200704 General Manager) |
General Manager (management) |
Mettler-Toledo (Group) |
Switzerland |
| Peacock, Jonathan M. (Jon) (Arix Bioscience 201805 Chairman before Amgen + Novartis Pharmaceuticals AG CFO + McKinsey) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Amgen (Group) |
United States (USA) |
| Pearse, Mark (LGC 201710 Managing Director of LGC Forensics) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
United Kingdom (GB) |
| Pearson, J. Michael (Valeant 200803 CEO) |
Chief Executive Officer (CEO) |
Valeant (Group) |
United States (USA) |
| Pearson, Sue (International Science Writer 201409) |
Public Relations Manager / Investor Relations Manager |
International Science Writer Ltd. (ISW) |
United Kingdom (GB) |
| Pedersen, Maireadh (Quay Pharmaceuticals 202112 CEO) |
Chief Executive Officer (CEO) |
SGS (Group) |
United Kingdom (GB) |
| Pehl, Michael (Gemoab 201907– Managing Director (CEO) before Immunomedics + Celgene + Amgen) |
Chief Executive Officer (CEO) |
Cellex (Group) |
Germany |
| Pehlemann, Werner (Biofrontera 200601– CFO before own firm + Dresdner Bank) |
Chief Financial Officer (CFO) |
Biofrontera (Group) |
Germany |
| Pein, Claus-Dietmar (Lonza 201211 Global Head of Marketing Lonza Bioscience Research and Testing Products) |
Sales Manager / Marketing Manager |
Lonza (Group) |
Switzerland |
| Peine, Günter (BioTop 200503) |
n. a. |
Berlin (govt region) |
Germany |
| Peiniger, Michael (Bruker 200904 Managing Director + minority owner RI Research Instruments GmbH) |
Managing Director |
Bruker (Group) |
Germany |
| Pelkmans, Lucas (ETH Zurich 200603) |
n. a. |
ETH Zürich (ETHZ) |
Switzerland |
| Pellengahr, Klaus (Novo Group 201807– General Manager at Organobalance before Director BusDev) |
General Manager (management) |
Novo Group (Group) |
Germany |
| Pellini, Michael J. (Mike) (Section 32 201712– Managing Partner before Foundation Medicine + Clarient) |
Chief Executive Officer (CEO) |
Section 32 LLC |
United States (USA) |
| Pellon-Consunji, Marina (Ampersand 202107 Partner at Ampersand Capital Partners) |
Partner (venture partner) |
Ampersand (Group) |
United States (USA) |
| Pellosniemi, Jaakko (Mobidiag 200803 CEO) |
Chief Executive Officer (CEO) |
Hologic (Group) |
Finland |
| Pelster, Dirk (Trion Pharma 201106 COO) |
Chief Operating Officer (COO) |
Trion Pharma GmbH |
Germany |
| Pelzer, Frank (JPK Instruments 201104 CEO) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Germany |
| Penner, Ralf (Paion 201011 Director Investor/Public Relations) |
Public Relations Manager / Investor Relations Manager |
Paion (Group) |
Germany |
| Penninger, Josef (IMBA + Uni Toronto + Uni Wien 200502) |
n. a. |
Austrian Academy of Sciences (ÖAW) |
Austria |
| Peplies, Jörg (Ribocon 2005– co-founder + managing director) |
Research & Development Manager |
Ribocon GmbH |
Germany |
| Peplow, Jörn (Eppendorf 201111 Managing Director of Starlab GmbH) |
Managing Director |
Eppendorf (Group) |
Germany |
| Perakslis, Eric (Roivant 201804 CSO of Datavant + former Chief Information Officer at FDA) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Roivant (Group) |
United States (USA) |
| Percy, Adrian (Bayer 201502 Head Global RnD at Bayer CropScience) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Pereira, Claney Lebev (GlycoUniverse 201310– Managing Director + Co-founder) |
Managing Director |
GlycoUniverse (Group) |
Germany |
| Perettie, Cindy (Roche 201902– CEO of Foundation Medicine before Roche/Genentech + Ivax + Élan) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Periat, Jean-Paul (Herculis Partners 201503 CEO) |
Chief Executive Officer (CEO) |
Herculis Partners S.A. |
|
| Pering, Christiane (Bayer 201501 CMO + Head Innovation of Medical Care division of Bayer HealthCare) |
Chief Medical Officer (CMO) |
Bayer (Group) |
Germany |
| Perkin, Eleanor (Huntsworth 202109 at Medistrava Consulting) |
Public Relations Manager / Investor Relations Manager |
Huntsworth (Group) |
United Kingdom (GB) |
| Perl, Thomas (Eyesight & Vision 201110 Managing Director Sales + Marketing) |
Managing Director |
Eyesight & Vision GmbH |
Germany |
| Perlitz, Uwe (Deutsche Bank Research 200503) |
Analyst (Financial / Industry) |
Deutsche Bank (Group) |
Germany |
| Perlmutter, Roger M. (Merck (US) 2013– EVP + President of Merck Research Labs before Amgen 2001–2012) |
President/Director/Head Business Group/Unit/Division |
Amgen (Group) |
United States (USA) |
| Perpeet, Markus (SAW Instruments 2010– Managing Director + co-founder before Caesar Projektleiter S-sens biosensor) |
Managing Director |
NanoTemper (Group) |
Germany |
| Perreault, Paul (CSL 202006 CEO + Managing Director) |
Chief Executive Officer (CEO) |
CSL (Group) |
Australia |
| Perrier, Marine (Enterome 202103 Head of External Communications + IR before Citigate Dewe Rogerson) |
Public Relations Manager / Investor Relations Manager |
Enterome S.A. |
France |
| Perron, Hervé (GeNeuro 201702 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GeNeuro S.A. (Euronext Paris: GNRO) |
Switzerland |
| Perry, Benjamin (DNDi 201909 Senior Discovery Manager + Research Scientist) |
n. a. |
DNDi (Drugs for Neglected Diseases initiative) |
Switzerland |
| Perry, Matthew (BVF Partners 201308 Portfolio Manager at Biotechnology Value Fund) |
Investment Manager |
BVF Partners L.P. (Biotechnology Venture Fund) |
United States (USA) |
| Persigehl, Peter (Eurofins 201405 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Germany |
| Persson, Magnus (Eir Ventures 202007– Founding Parter before General Partner at HealthCap) |
General Partner (venture partner) |
Eir Ventures (Group) |
Sweden |
| Pertile, Paolo (Cutech 201905 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Italy |
| Peschen, Dieter (AgroProtec 2010– Managing Director + co-founder) |
Managing Director |
AgroProtect GmbH |
Germany |
| Pessara, Ulrich (IcanoMab 202009 CBO before Staatz Business Development + Strategy) |
Chief Business Officer (CBO) |
IcanoMab GmbH |
Germany |
| Pestano, Gary (Biodesix 201304 Head Product Development + Lab Operations) |
Research & Development Manager |
Biodesix Inc. |
United States (USA) |
| Peter, Jochen F. (SensScreen 200909– CEO + founder) |
Managing Director |
SensScreen Technologies GmbH |
Germany |
| Peter-Katalinic, Jasna (Univ Münster 1996– Professor before Univ Bonn before Texas A+M Univ before Univ Zürich) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Péterfy, Ferenc (Diagnosticum (HU) 201708 President) |
President/Director/Head Business Group/Unit/Division |
Diagnosticum (HU) (Group) |
Hungary |
| Peters, Andreas C. (GSK Stockmann 201704 Lawyer at Hamburg Office) |
Attorney / Lawyer |
|
|
| Peters, Björn (CDR-Life 202204 CBO) |
Chief Business Officer (CBO) |
CDR-Life AG |
Switzerland |
| Peters, Dirk (Assaymatic GmbH 201110 Managing Director) |
Managing Director |
Assaymatic GmbH |
Germany |
| Peters, Malte (MorphoSys 201703– Chief Development Officer before Sandoz International + Novartis + Micromet) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
MorphoSys (Group) |
Germany |
| Peters, Ole (Bayer 201612 Digital Farming Technology Lead at Bayer CropScience) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Peters, Sabine (Amodia Bioservice 2003) |
n. a. |
Amodia Bioservice GmbH |
Germany |
| Peters, Sonja (Q-Bioanalytic 200607) |
n. a. |
Eurofins (Group) |
Germany |
| Peters, Wilt (Molecular Sensing 201112– Managing Director of Molecular Sensing GmbH) |
Managing Director |
Molecular Sensing (Group) |
Germany |
| Petersen, Kaj (Gerstel 201003 Marketing Manager) |
Sales Manager / Marketing Manager |
Gerstel (Group) |
Germany |
| Peterson, Sandra E. (JnJ 201212– before Bayer 201010–201211 CEO of Bayer CropScience before Bayer HealthCare) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
| Petkov, Jordan (Lonza 201703– Global Head of Research + Technology at Lonza Consumer Care before KLK POleo + Unilever) |
Research & Development Manager |
Lonza (Group) |
Switzerland |
| Petraß, Jörg (Mologen –201512 CFO LEFT 12/15) |
Chief Financial Officer (CFO) |
Mologen (Group) |
Germany |
| Petri, Alfred (Evonik 201308 SVP Sales + Marketing of Health + Nutrition Business Unit) |
Sales Manager / Marketing Manager |
Evonik (Group) |
Germany |
| Petrone, Raffaele (Therametrics 201310– CEO) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
| Petrovic, Shacey (Insulet 202007 CEO) |
Chief Executive Officer (CEO) |
Insulet Corporation |
United States (USA) |
| Pettigrew, Michel (Ferring Pharmaceuticals 200105– COO before BMS) |
Chief Operating Officer (COO) |
Ferring (Paulsen Foundation) (Group) |
United Kingdom (GB) |
| Petzholdt-Gühne, Grit (Analytik Jena 201306– Head of Huma Resources before Schott AG Jena + Daimler + Coca Cola) |
Human Resources Manager |
Endress+Hauser (Group) |
Germany |
| Peukert, Uwe (ActeaVentures 201403– Managing Partner before Roche + Lilly + Onyx + NewVac) |
Managing Director |
ActeaVentures GmbH |
Germany |
| Peyer, James (Apollo Ventures 201902 Managing Partner) |
Managing Partner |
Apollo Ventures Holding GmbH (Apollo Health Ventures, AHV) |
Germany |
| Peyro-Saint-Paul, Helene (PathoQuest 201610 CMO) |
Chief Medical Officer (CMO) |
PathoQuest S.A.S. |
France |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [iito] Life Science Business Portals Media Data 2022 650x100px](/banner/iito-business-intelligence-20220406-650-100-get-in-front-of-decision-makers.jpg)
1 2 3 ... 52 53 54 ... 79 80 81 
![Picture [iito] Männer Ballett 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
